C
AbbVie Inc. ABBV
$210.60 $1.100.53% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -29.52% -30.00% -12.03% -21.37% -38.53%
Total Depreciation and Amortization -2.89% -3.40% -3.59% -4.77% -2.66%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 107.08% 126.57% 38.04% -29.04% -19.47%
Change in Net Operating Assets -4,190.77% -244.90% -198.90% -160.39% -103.11%
Cash from Operations 3.46% -27.70% -17.66% -35.29% -27.03%
Capital Expenditure -21.68% -27.80% -25.35% -13.12% -15.48%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -7.50% -13.71% -1,577.60% -1,887.42% -1,098.47%
Divestitures -- -- -- -- --
Other Investing Activities 1,389.83% 1,725.00% 7,555.56% 328.57% -103.57%
Cash from Investing -1.58% -7.83% -936.34% -1,091.67% -592,850.00%
Total Debt Issued -42.17% -62.01% -- -- --
Total Debt Repaid -26.27% -58.60% -252.40% -15.72% 13.88%
Issuance of Common Stock -32.35% -40.91% 18.89% 16.34% 15.25%
Repurchase of Common Stock -0.60% -0.30% 13.39% 31.42% 32.08%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -5.23% -4.96% -4.61% -4.61% -4.65%
Other Financing Activities 121.43% 108.35% 94.34% 90.11% 84.53%
Cash from Financing -482.12% -8,093.36% 69.74% 87.51% 90.55%
Foreign Exchange rate Adjustments 105.00% -80.95% -1,400.00% -20.00% 47.37%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -252.44% -213.53% -301.77% -514.43% 1,736.55%